ENLV SPIKES ON BIG VOLUME AND TOP LINE RESULTS FROM PHASE I
ENLV spikes on Report for Positive Results from Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients . Anice momentum up for a intraday trading.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.